Morgan Stanley On Biogen: Here's The 'Other' Coming Tysabri Catalyst
June 23, 2015 at 10:51 AM EDT
In a report published Tuesday, Morgan Stanley analyst Matthew Harrison maintained an Overweight rating on Biogen Inc (NASDAQ: BIIB), ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.